UroVaxom
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
UroVaxom (developmental code names OM-89, OM-8980) is a vaccine against urinary tract infections (UTIs). It is an extract of 18 strains of killed Escherichia coli administered as an oral tablet once daily for 3 months. The vaccine is marketed for use in the prevention of recurrent UTIs in some European countries.
It was also being studied for treatment of prostatitis but was discontinued. UroVaxom was initially developed in the 1980s.
UroVaxom (developmental code names OM-89, OM-8980) is a vaccine against urinary tract infections (UTIs). It is an extract of 18 strains of killed Escherichia coli administered as an oral tablet once daily for 3 months. The vaccine is marketed for use in the prevention of recurrent UTIs in some European countries.
It was also being studied for treatment of prostatitis but was discontinued. UroVaxom was initially developed in the 1980s.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1277725666 under CC BY-SA 4.0; modifications have been made.